Notice of Intent to Sole Source PacBio Reagents

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Pacific Biosciences for reagents. This is the only product that will function to generate sequence data for our instruments. No other companies manufacture products compatible with this instrument. Each company that manufactures an instrument capable of generating sequence data has their own proprietary chemistry, reagents, and kits and only those products can be used to operate the instrument. Within a given company that makes different types of instruments, each instrument has specific reagents and plastic consumables that are required to operate the instrument. There are no options to purchase these from other companies or even to use the reagents meant for one instrument in another instrument that is made by the same company. Therefore, this is the only set of reagents that will allow us to continue to operate our only high- capacity sequencing instrument for the COVID-19 surveillance work we are doing. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to William Brannen at [email protected] by 10:00 A.M. EST November 22, 2022